AnaptysBio, Inc. (NASDAQ: ANAB), a biotechnology firm based in San Diego, California, is capturing investor attention with its impressive potential upside of 79.12%. Specializing in discovering..
AxoGen, Inc. (NASDAQ: AXGN), a leader in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is capturing investor attention with its innovative approach..
AtaiBeckley Inc. (NASDAQ: ATAI) continues to intrigue investors with its pioneering approach in the biotechnology sector, specifically focusing on mental health treatment innovations. With a market..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing the attention of investors with its promising pipeline and a remarkable potential upside of 138.96%. As a clinical-stage biopharmaceutical..
Definitive Healthcare Corp. (NASDAQ: DH) stands at a pivotal juncture for investors keen on exploring opportunities within the healthcare sector. As a provider of healthcare commercial..
Savara, Inc. (NASDAQ: SVRA), a prominent player in the biotechnology sector, is making waves with its promising developments in rare respiratory diseases. As a clinical stage..
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, is generating buzz among investors due to its notable potential upside of nearly 27.44%. As..
Weave Communications, Inc. (NYSE: WEAV), a key player in the health information services sector, continues to attract attention with its innovative AI-powered communication solutions tailored for..
Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, specializes in drug manufacturing with a focus on specialty and generic products. With..
Investors eyeing the healthcare sector might want to consider Altimmune, Inc. (NASDAQ: ALT), a biopharmaceutical company with a tantalizing potential upside of 625%. Altimmune, based in..
Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology landscape with its promising portfolio of G protein-coupled receptor (GPCR) oral small molecule products aimed at treating..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is carving a niche in the healthcare sector with its innovative approach to tackling infectious diseases, specifically..
Keros Therapeutics, Inc. (NASDAQ: KROS), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 78.68%, according..
Sana Biotechnology, Inc. (NASDAQ: SANA) is a name that has been increasingly catching the attention of investors in the healthcare sector. With a compelling potential upside..
For investors seeking opportunities in the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents an intriguing case. As a pharmaceutical company specializing in health security, SIGA..
Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors with its promising potential upside and a solid lineup of buy ratings from analysts. As a..
For investors eyeing the healthcare sector, Auna SA (AUNA) presents an intriguing opportunity. Based in Luxembourg, Auna operates a network of hospitals and clinics across Mexico,..
Investors looking for significant upside potential in the biotech sector might want to take a closer look at Inventiva S.A. (NASDAQ: IVA), a French clinical-stage biopharmaceutical..
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing the spotlight in the biotechnology sector with a compelling 37.70% potential upside, according to recent analyst ratings. As a..
